Locations:
Search
Test helpful for SLN-negative, stage I to IIA and thin tumors
Earlier detection of certain cancers a likely result
Toward detailed, personalized maps of identified and interpreted genomic variation
S6K1 pathway could be a promising therapeutic target
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Understanding resistance in PARP inhibitor therapy
Two new studies add insights and home in on therapeutic targets
Understanding the role of nitric oxide and hyaluronan in asthma
Discovery of new MS subtype suggests that the axon itself may be primary site of injury
Dr. Jianjun Zhao receives two-year grant
Rationale and status reports on mechanistically varied strategies
Advertisement
Advertisement